How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion Pharmaceuticals reported Q2 2026 results showing a significant decline in revenue but highlighted key advancements in its drug development pipeline. The company is focusing on AI-driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results